Millennium Food-Tech-Limited

Investor Presentation • Dec 2, 2024

Investor Presentation | December 2024

Smart Food-Tech Investments

Disclaimer & Forwardlooking Information

This presentation was prepared by Millennium Food-Tech - Limited Partnership (the "Partnership") as a general presentation about the Partnership. As such, the information it includes is only an extract, and does not cover all of the information about the Partnership and its operations. Therefore, this presentation does not describe the Partnership's operations fully and in detail, and it is not intended to replace the need to review the Partnership's reports to the public, including the supplementary prospectus and the shelf prospectus of the Partnership (the "Prospectus"), which should be read together with the reports published by the Partnership by law. The information included in this presentation does not purport to survey or include all of the information that could be relevant for the purpose of reaching any conclusion related to investment in the securities of the Partnership. The information regarding the portfolio companies is based on information received from each of the portfolio companies with respect to itself.

The Partnership is also not obligated to update or change the information included in the presentation so that it reflects events or editing, processing or segmentation that differ from the current depiction in the presentation, or changes that take place after the date of its preparation.

This presentation includes forward-looking information, as defined in the Securities Law - 1968, including outlooks, evaluations, estimates and other information related to the events and matters that will take place or may take place in the future, including with regard to the outlook on income and profitability, whose occurrence is not certain and is not under the exclusive control of the Partnership.

Forward-looking information in the presentation is based on estimates and assumptions of the management of the Partnership as of the date that the presentation was prepared, which are uncertain by their nature, due to their dependence on the risks inherent in the Partnership's operations, and which are not under the Partnership's control, each of which, or a combination thereof, is liable to harm the results of the Partnership's operations and, consequently, the realization of these estimates and outlooks.

The presentation includes statistical data and publications that were published by third-parties, the content of which was not examined by the Partnership, and the Partnership is not responsible for their validity.

The information included in the presentation does not constitute a proposal or invitation to make an offer to purchase the Partnership's securities.

Management Team

GUY ROSEN | CHAIRMAN

Vice Chairman and representative of the kibbutzim at Tnuva, Israel's largest food company. Board member at various public companies and at Mizrahi Invest. Guy, an attorney by profession, has a Bachelor of Laws (LL.B.) from Tel Aviv University, a Master of Business Administration (MBA) from IDC Herzliya and is a graduate of the Advanced Management Program at Harvard Business School.

Guy has extensive experience as a chairman and board member of public and private companies, including Albad, Isramco, IsraAir and Beit Shemesh Engines, as well as in the venture capital sphere as Chairman at Maayan Ventures and an active board member at Infinity I-China.

OREN ATTIYA | CEO

Oren has extensive experience in the Venture Capital and Capital Market. Oren has served as the CFO of several start-ups and incubators in the high-tech, life-science, and Food-Tech sectors. Oren led and accompanied many IPOs and M&As. Oren was an Audit Manager at PwC Israel and holds a BA in Accounting and Economics and is a member of the ICPA.

NILI ZUR | Director

Experienced manager with extensive knowledge in the food and beverages sector. Nili has led several businesses in Israel and abroad toward profitability and growth, specializing in Food-Tech and implementing penetration strategies for innovation in traditional markets. In her various positions, she has managed several business divisions at Osem-Nestle in Israel and abroad, as well as managing the Wissotzky Group.

Our Portfolio

Leading Israeli Innovation

\$2.8M Investment

Utilizes a novel, fermentation-based technology to produce natural betalain (purple to yellow) colors from yeast

Please refer to Spotlight slides Please refer to Spotlight slides

Develops, produces, and sells fully compostable flexible packaging and films for the food industry

FDB – 10.82% FDB – 5.57% FDB – 10.62% FDB – 14.1%

Develop and sells a technology that upcycle Food Waste into valuable bio-materials

Please refer to Spotlight slides

Provides diversity of fast Scan & Go and Payment Solutions based on AI, Imaging and Big data for any type of retailer

FDB – 11.9%

Please refer to Spotlight slides

\$2.5M Investment

Developed a personalized and digitized 3D printing of meat alternatives for Restaurants and Food Service

Up-Round Up-Round Up-Round IPO TASE: SVRT

FCC regulatory approval.

Commercial Agreement signed U.S. Expansion in 2025.

secured another 500K investment in doubled from fair value (German VC).

Our Portfolio

Leading Israeli Innovation

\$1 .2M Invest ment	\$2 .1M Invest ment	\$1M Invest ment	\$2 .83M Invest ment	\$4M Invest ment
Develops Plant-Based egg replacement for various application in the food manufacturing processes	Developed, produces and sells delicious, clean label, plant-based dairy substitutes – Impairment of 100% from cost of investment	First-party data platform designed for CPG & beauty brands, which enables D2C brands to monetize first-party data	Developed a sustainable deep-technology to roast on demand World's Freshest coffee from green coffee beans	Developed a healthy and ethical way to produce cultured whole-cut steaks
FDB – 17.79%	FDB – 19.05%	FDB – 98%	FDB – 11.88%	FDB – 1.3%
Two ongoing pilots with leading enterprise	Currently exploring strategic opportunities to leverage the company's existing assets	We have assumed control of the company and are currently exploring strategic opportunities to leverage the company's existing assets	Pivoting company product to - "from farm to coffeeshop experience"	Burn rate reduction of ~40% to extend runway - for scalability and production efficiency Regulatory approval in the form of a "No Questions" letter from Israel's Ministry of Health for its cultivated beef manufacturing process

Key Milestones and current status

• 1. Initial Investment- Sep 2020: MFT invested \$1.8M in Phytolon (SAFE agreement).
• 1. Strategic Partnership- Feb 2022: Phytolon partnered with Ginkgo Bioworks to develop advanced yeast strains.

3. 14.5M\$ Series A Up-Round- Jun 2022:

• ○ Led by Royal DSM's venture arm, with support from Ginkgo.
• ○ MFT invested an additional \$1M, securing a total holding of 10.82% (on FDB).
• Secured a two years commercial agreement with DSM-Firmenich, a global leader in nutrition.

4. Commercial Manufacturing Milestone:

• The company has signed an agreement with a Contract Manufacturing Organization (CMO), enabling commercial manufacturing capabilities.
• 1. Regulatory Progress 2024:
  2. Achieved clearance of the FDA regulatory route, and made advanced progress towards FDA approval.
• 1. Rich's investment and commercial agreement- Nov 2024:
  2. Secured an investment from Rich's, leading U.S. whipped cream brand.
  3. Entered into a non-exclusive collaboration agreement to incorporate Phytolon's revolutionary natural color solutions.

Key Milestones and current status

• 1. Initial Investment- Ap 2021: MFT invested \$3M in TripleW (SAFE agreement).
• 1. European Union grant- Jul 2021: TripleW Secured a €2.2 million non dilutive grant from the European Union.
• 1. TripleW \$16.5m Series B Led by Firstime VC (Upround) Mar 2023:
  2. MFT participated with an additional \$0.6M investment in the funding round, reaching a stake of ~10% (on FDB).
  3. Among the investors in this round where Firstime VC, LG Ventures, GS Ventures, Israel Oil and Gas Fund, which further validating the company's market potential.

• 1. 15M\$ Non dilutive European Horizon Grant 2024: Awarded a \$15M non-dilutive grant from Horizon Europe as part of a European consortium, which includes industry leaders such as LG Chem, Volkswagen (VW), and Renewi.
• 1. Major Partnerships and Expansion 2024 :
  2. Antwerp Project: Secured a €9.5M CAPEX grant from the EU Innovation Fund for the development of a facility in Antwerp to produce Circulac, a revolutionary organic waste-derived lactic acid.
  3. ○ Amsterdam Project: Signed MOU with Renewi to develop a production site converting food waste into sustainable materials.
• 1. Investor Confidence- 2024 : TripleW investors exercised \$3.8M in warrants at a 25% higher valuation than Series B. MFT added \$300K and now holds 9.2% on FDB.

• 1. Key Partnerships and investments: Bizerba & Osher Ad Feb 2021:
  2. Bizerba a global retail leader, led the funding round, Osher Ad (Leading Israeli retailer) participated.
  3. Bizerba contributed capex capabilities and leveraged their sales network to drive market expansion.
• Osher Ad has implemented Supersmart's solutions across their supermarket chain in Israel, which are fully operational and automating a significant portion of their daily sales process.
• 1. MFT Initial Investment- Jan 2022:
• MFT led a SAFE round of up to \$10 million in Supersmart, investing \$3 million.
• Major partners Bizerba and Osher Ad, also participated.
• 1. MFT follow on investments in Supersmart 2022-2024:
  2. MFT makes a second \$2M investment of under the same open SAFE agreement (Aug 22).
  3. MFT invested another total of ~900K\$, and holds a total of ~12% (in FDB).
• 1. Double Digit Revenue Growth 2023-2024: Achieved a 20% year-over-year increase in ARR.
• 1. Accelerated Store Deployment 2023-2024: Achieved approximately 40% year-over-year growth in store count.
• 1. Supersmart solution Trusted by leading retailers across the Globe: COOP, HEB, Tesco, Metro, Spar, Selgros Germany, Osher Ad, Jeronimo Martins.

Key Milestones and current status

• 1. Initial Investment- Dec 2020: MFT invested \$4M in Tipa corp through a SAFE round.
• 1. MFT Led a \$70M C Funding Round Jan 2022:
  2. ○ MFT Invested \$4M in the round alongside Meitav Dash, Blue Horizon Fund, and other strategic investors.
  3. Achieved a 3.3% fully diluted equity stake in TIPA.
• 1. Major Secondary Opportunity, Strengthening Our Stake in TIPA Corp- Aug 2024:

MFT seized a fortunate opportunity to acquire an additional 2.3% of TIPA Corp for \$500K, raising our fully diluted equity stake to 5.57%.

4. Major company milestones - 2023-2024:

• ○ Acquired a German based company "Bio4Pack" to accelerate the European business. The Integration was successfully implemented.
• Established a sales and operations front office in the US while recruiting seasoned executives to lead the US business.
• ○ Achieved a double digit year-over-year increase in sales.
• Reached double-digit sales figures (in M\$), showcasing strong demand and market traction.
• ○ Actively examine major partnership opportunities with industry giants to accelerate growth.

Main Partnership 30/06/2024

Main		148M NIS	Total amount raised by the Fund
Data As of		82M NIS	Total fair value of investments in portfolio companies
	As of today *	8.8M NIS	Cash & securities fair value
	Cash, securities & investments in portfolio companies	94M NIS	Total NAV
		3.5M NIS Annual	Partnership OPEX
	As of today *	12M NIS	Partnership Market Cap
			Investor Presentation April 2023	11

Capital Raising Terms Rights Offering

• Capital raise of up to 11.7M NIS (in case of full exercise), in a mechanism of rights offering.
• Each holder of 1 participation unit is entitled to purchase 1 participation unit in a price of 1.8 NIS.
• The offering date: 02/12/2024.
• X Day Date: 09/12/2024.
• Trading rights date: 19/12/2024.
• Final exercises date: 24/12/2024.
• The raised amount is intended mainly for continued investment in the existing portfolio companies of the fund.
• For the success of the fundraising, the General Partner has approved their participation in the current offering and will maintain at least their proportional share.

+972-54-647-0945 | Oren Attiya, CEO Oren@millennium-ft.com | www.Millennium-ft.com